Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...
Werewolf’s PREDATOR protein engineering technology creates biological prodrugs that remain inactive in the systemic circulation. These prodrugs are activated into immune stimulants only in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback